You are currently on the new version of our website. Access the old version .
  • Correction
  • Open Access

14 May 2025

Correction: Park et al. Protective Effects of Nargenicin A1 against Tacrolimus-Induced Oxidative Stress in Hirame Natural Embryo Cells. Int. J. Environ. Res. Public Health 2019, 16, 1044

,
,
,
,
,
,
,
,
1
Department of Molecular Biology, College of Natural Sciences, Dong-eui University, Busan 47340, Korea
2
Department of Biochemistry, Dong-eui University College of Korean Medicine, Busan 47227, Korea
3
Department of Pharmacy, College of Pharmacy, Inje University, Gimhae 50834, Korea
4
National Marine Biodiversity Institute of Korea, Seocheon 33662, Korea
In the original publication [1], there was a mistake in Figure 2B,C. This data error occurred due to an unforeseen mistake during the data organization process. The corrected Figure 2 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 2. Suppression of tacrolimus-induced apoptosis by nargenicin A1 in HINAE cells. HINAE cells were treated with 10 μM nargenicin A1 or 10 mM NAC for 1 h, and then stimulated with or without 25 μM tacrolimus for 24 h. (A) Cells were collected, fixed, stained with 4,6-diamidino-2-phenylindole (DAPI), and photographed under a fluorescence microscope (original magnification, ×400). Scale bar, 50 µm. (B,C) Cells cultured under the same conditions were collected and stained with fluorescein isothiocyanate (FITC)-conjugated annexin V and propidium iodide (PI) for flow cytometry. (B) Results showed necrosis, defined as annexin V-negative and PI-positive cells (lower upper quadrant); early apoptosis, defined as annexin V-positive and PI-negative cells (lower right quadrant); and late apoptosis, defined as annexin V-positive and PI-positive (upper right quadrant) cells. (C) Percentages of apoptotic cells were determined by expressing the number of annexin V-positive cells as a percentage of all cells present. Results are presented as the means ± SD of three independent experiments (* p < 0.05 versus non-treated controls, # p < 0.05 versus tacrolimus-treated cells).

Reference

  1. Park, C.; Kwon, D.H.; Hwang, S.J.; Han, M.H.; Jeong, J.-W.; Hong, S.H.; Cha, H.-J.; Hong, S.-H.; Kim, G.-Y.; Lee, H.-J.; et al. Protective Effects of Nargenicin A1 against Tacrolimus-Induced Oxidative Stress in Hirame Natural Embryo Cells. Int. J. Environ. Res. Public Health 2019, 16, 1044. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.